10mg Semaglutide Reconstitution: What the Search Results Aren't Telling You

Licensed semaglutide for weight management in the UK (Wegovy) is supplied as a ready-to-use pre-filled pen — reconstitution is not part of any approved UK dosing process.
"10mg semaglutide" does not correspond to any dose in Wegovy's licensed schedule, which runs from 0.25mg up to 2.4mg (and a newer 7.2mg maintenance dose approved in April 2026).
Compounded or reconstituted semaglutide products are not licensed by the MHRA for weight management and carry serious safety risks, including dosing errors and contamination.
The MHRA has warned publicly about counterfeit and unlicensed weight-loss injectables sold online; a legitimate supply always requires a prescription following clinical assessment.

If you've searched for 10mg semaglutide reconstitution, here is the direct answer: there is no licensed 10mg reconstituted semaglutide product approved in the UK. Wegovy, the only semaglutide medicine licensed here for weight management, comes as a pre-filled, pre-mixed injection pen — no mixing, no vials, no needles from a separate syringe. A "10mg reconstituted" formulation belongs to the compounding and grey-market world, not the licensed supply chain. That distinction matters enormously when the substance in question is a prescription-only medicine.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding why reconstitution queries about semaglutide signal real safety risks

You've seen someone online mixing semaglutide from a powder, and now you're wondering if that's what you're supposed to do

It's a reasonable confusion. Scroll through any weight-loss forum and you'll find threads about vials, bacteriostatic water, syringes and something labelled "semaglutide 10mg powder". The people posting there often genuinely believe they're doing the equivalent of what a pharmacy does. They're not.

Reconstitution, in a pharmaceutical context, means dissolving a lyophilised (freeze-dried) powder in a precise sterile diluent under controlled conditions, then drawing an exact volume into a syringe to deliver a calibrated dose. Pharmaceutical manufacturers do this under strict sterile manufacturing standards, cleanroom environments, validated equipment, stability testing. Doing it at home with a vial bought from a research chemical supplier introduces variables that cannot be controlled: sterility, concentration accuracy, degradation of the peptide, and the real possibility of injecting the wrong dose by an order of magnitude.

Licensed Wegovy pens contain semaglutide in a stable, pre-measured solution. You dial the dose, attach a needle, inject. There is no powder, no mixing, no calculation. The pen's design is deliberate, it removes the steps where errors happen. Patients using Wegovy as a licensed treatment never need to reconstitute anything.

The "10mg" figure that appears in many of these queries almost certainly refers to the total content of a research vial, not a single dose. The licensed maintenance dose of semaglutide for weight management is 2.4mg weekly (or 7.2mg with the newer pen, approved by the MHRA in April 2026). If you have come across a vial labelled 10mg and want to understand what that process actually involves, our guide to reconstituting 10mg semaglutide explains why it would theoretically contain multiple doses, which is precisely why home reconstitution carries such serious overdose risk.

What the MHRA has actually found when these products are tested

This is not a theoretical concern. The MHRA has issued repeated warnings about unlicensed weight-loss injectables sold online and through social media. In October 2023 the agency warned the public about counterfeit pens containing insulin rather than the stated GLP-1 medicine. Through 2025, enforcement operations seized approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million, and a raid in Northampton uncovered the UK's first illicit site manufacturing counterfeit tirzepatide pens.

Semaglutide powder sold for reconstitution falls into the same category of unverified supply. There is no way for a buyer to confirm the actual concentration, purity or sterility of a product that has not passed through MHRA-regulated manufacturing and testing. You can report suspected unlicensed sellers via the MHRA's Yellow Card scheme, which accepts reports from patients as well as healthcare professionals.

The NHS medicines information on semaglutide covers the licensed product and its side-effect profile, worth reading if you're weighing up whether semaglutide is right for you, because that information applies to the pharmacy-grade medicine, not to anything compounded or reconstituted.

If you're curious about how the licensed dose schedule actually works, the Wegovy dose progression page walks through each stage clearly.

Why this query often comes from people who are genuinely trying to save money, and what to consider instead

Honestly, the economics make sense on the surface. A vial of powder costs less than a licensed pen. And private semaglutide prescriptions are not cheap, Eli Lilly's price increase for tirzepatide in autumn 2025 pushed media attention onto cost across the whole GLP-1 category, and Wegovy prices have followed a similar trajectory for different reasons. If you're paying out of pocket and you see a cheaper alternative, the appeal is understandable.

But the saving is illusory once you factor in what you're taking on. Without a prescription and clinical oversight, you have no baseline assessment, no dose escalation reviewed by a prescriber, no one to call if side effects hit hard. A prescriber's job at each stage is not just to adjust the number on the pen, it's to check your response, your weight, your bloodwork picture and whether you should continue. That process is what produces the outcomes seen in clinical trials.

For an honest look at what private treatment costs in the UK and what those costs include, the Wegovy pricing and access page sets it out plainly. Separately, if lifestyle factors and what to expect from treatment are what you'd like to explore first, the weight-loss treatment overview is a good place to start.

It is also worth noting that semaglutide interacts with the absorption of oral medicines, patients on oral contraceptives, for example, are advised to use a barrier method for four weeks after each dose increase. Questions like how semaglutide affects oestrogen levels are the kind of thing a prescriber works through with you at consultation. A vial bought online comes with none of that.

The route to licensed semaglutide in the UK

The legal route is a prescription from a registered prescriber, following a clinical assessment that confirms you meet the eligibility criteria for the licensed medicine. For Wegovy, that broadly means a BMI of 30 or above, or 27 or above alongside a weight-related health condition. Lower thresholds apply for some ethnic backgrounds under UK guidance.

At nume, a GPhC-registered Independent Prescriber (a real clinician, not automated software) reads your consultation the same day. You can verify our pharmacy on the GPhC register (registration number 9012878). Identity and weight are verified before any prescription is issued; the medicine travels from the licensed supply chain, via our pharmacy, to you.

One thing patients often don't anticipate: the timing of their first order can affect when they start. Order by 12pm on a weekday and, once clinically approved, the pen dispatches the same day. That matters if you've been planning to start around a particular date, say, after a holiday or at the beginning of a new month when it feels right to commit. If questions arise about lower-strength preparations, our page on 5mg semaglutide reconstitution explains the context, and our FAQs cover what to expect from the licensed process in more detail.

If you're ready to speak with our prescribers about whether licensed semaglutide is right for you, start your free consultation here.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions